Active	Status	Sponsor type	Region	Phase	Filter
4 Active 3 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rush, David
NCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant	Active, not recruiting	2/3	420	Canada, RoW	Kidney transplant biopsy, Protocol biopsy	University of Manitoba, Canadian Institutes of Health Research (CIHR), Canadian National Transplant Research Program	Kidney Transplant; Complications, Rejection of Renal Transplant	06/24	09/25
Nickerson, Peter
IMAGINE, NCT03744910 / 2018-003682-34: Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients	Terminated	3	194	Europe, Canada, US, RoW	Clazakizumab, Physiologic saline solution	CSL Behring, ICON Clinical Research	Antibody-mediated Rejection	04/24	04/24
NCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant	Active, not recruiting	2/3	420	Canada, RoW	Kidney transplant biopsy, Protocol biopsy	University of Manitoba, Canadian Institutes of Health Research (CIHR), Canadian National Transplant Research Program	Kidney Transplant; Complications, Rejection of Renal Transplant	06/24	09/25
NCT05917522: Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation	Recruiting	2	800	US	Abatacept, Orencia, Standard of Care at US Transplant Centers	National Institute of Allergy and Infectious Diseases (NIAID)	Kidney Transplant	07/27	07/29